Gritstone bio Inc reports results for the quarter ended in December - Earnings Summary

Gritstone bio

09/03/2023 22:49

* Gritstone bio Inc  GRTS.OQ  reported a quarterly adjusted
loss
of 30 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 34 cents per share.
    * Revenue rose 39.1% to $4.26 million from a year ago;
analysts
expected $2.90 million. 
    * Gritstone bio Inc's reported EPS for the quarter was a
loss
of 30 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Gritstone bio Inc shares had fallen by 31.0% this quarter.
    * The company reported a quarterly loss of $31.29 million.
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $6.42 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 10:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.34          -0.30          Beat
 Sep. 30 2022      -0.40          -0.35          Beat
 Jun. 30 2022      -0.40          -0.34          Beat
 Mar. 31 2022      -0.37          -0.34          Beat